title: Erythema Dyschromicum Perstans Response to Isotretinoin.
authors.affiliation: Department of Dermatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
authors.forename: Fang
authors.initials: F
authors.lastname: Wang
authors.affiliation: Department of Dermatology, The Eastern Hospital of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
authors.forename: Yu-Kun
authors.initials: YK
authors.lastname: Zhao
authors.affiliation: Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
authors.forename: Zhuo
authors.initials: Z
authors.lastname: Wang
authors.affiliation: Department of Dermatology, The Eastern Hospital of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
authors.forename: Juan-Hua
authors.initials: JH
authors.lastname: Liu
authors.affiliation: Department of Dermatology, The Eastern Hospital of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
authors.forename: Di-Qing
authors.initials: DQ
authors.lastname: Luo
mesh_terms: D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004890:Erythema / Q000188:drug therapy* / Q000473:pathology*; D005148:Facial Dermatoses / Q000188:drug therapy* / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D017495:Hyperpigmentation / Q000188:drug therapy* / Q000473:pathology; D007150:Immunohistochemistry; D015474:Isotretinoin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D019233:Retreatment; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015474:Isotretinoin